While high costs and other challenges remain a concern, specialty drugs including biologics and biosimilars should be continually evaluated for potential benefits to injured workers, as they may provide relief that traditional therapies cannot. (Credit: Kenishirotie/Stock.adobe.com)
When we talk about addressing pharmacy issues in workers' compensation programs, opioid concerns often appear at the top of the agenda, and while opioid management remains an important focus, it is not the only pharmacy trend we must watch closely.
High-impact categories such as topicals, compound kits, combo packs, and specialty medications represent proportionately low utilization, however, they can be associated with exponentially higher costs. In order to effectively manage clinically appropriate utilization and savings within these classes, it is important to recognize the trends associated with each of these cost drivers.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
